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SUMMARY. Medicine, as an instrument for health promotion, can be considered a risk factor when used
inappropriately or when its quality is compromised. It is for the manufacturer to produce medicine meet-
ing quality standards and for the State to monitor and regulate the whole supply chain process. The re-
sults of this study come from 306 sample medicines analysed by the Antibiotics Section of the Adolfo Lutz
Institute, by the Z and the National Programmes of Quality Control of Medicines in the period 2003-2009:
88 % were considered satisfactory while 12 % were unsatisfactory, of which 2 % due to labeling analyses
and 10 % to physicochemical analyses, mainly for the trials of visual aspect and dissolution.The laborato-
ry findings proved to be of great importance and relevance that the State implement programmes of quali-
ty control and that Central Laboratories of Public Health assure the execution of Good Manufacturing
Practices and the consumer defense directives. 
